CRISPR-based diagnostics for infectious diseases: mechanisms, advancements and clinical transformation prospects
Frontiers in Cellular and Infection Microbiology · 24.02.2026 · 16
DOI: 10.3389/fcimb.2026.1769226 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 24.02.2026. Verfasst von Zhenzhen Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, Molecular Diagnostic Techniques, Communicable Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infectious diseases continue to pose significant global public health challenges, necessitating the development of rapid, sensitive, specific, and field-deployable diagnostic platforms. The discovery of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated proteins (Cas) has revolutionized genome editing and concurrently enabled a new generation of molecular diagnostic tools. Leveraging the inherent trans-cleavage activities of Cas enzymes, platforms such as SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) and DETECTR (DNA Endonuclease-Targeted CRISPR Trans Reporter) have emerged, combining target recognition precision with reporter systems to achieve ultra-sensitive detection of pathogen-specific nucleic acids. This review systematically examines the mechanistic foundations of CRISPR diagnostics, synthesizes recent advancements in infectious disease applications, evaluates their advantages in sensitivity, specificity, operational simplicity, and multiplexing capacity, and critically analyzes current implementation barriers and future translational pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Pan, Z., Xu, L., Fan, Z., Cao, Y., & Ren, F. (2026). CRISPR-based diagnostics for infectious diseases: mechanisms, advancements and clinical transformation prospects. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1769226
Vancouver
Pan Z, Xu L, Fan Z, Cao Y, Ren F. CRISPR-based diagnostics for infectious diseases: mechanisms, advancements and clinical transformation prospects. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1769226
BibTeX
@article{Pan2026,
author = {Pan, Zhenzhen and Xu, Ling and Fan, Zihao and Cao, Yaling and Ren, Feng},
title = {CRISPR-based diagnostics for infectious diseases: mechanisms, advancements and clinical transformation prospects},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1769226}
}
EUVIMED